EICHORCondition: Liver Cirrhosis · Liver Cancer · HCC · Sponsor: Helio Genomics
The objective of this study is the acquisition of whole blood samples and serum samples from participants with untreated Hepatocellular Carcinoma (HCC) and subjects undergoing Hepatocellular Carcinoma (HCC) surveillance. These samples will be used for research purposes to develop and validate the Helio multi-analyte blood test.
This description comes directly from the study's public registry record.
Clinical Operations Manager, BSN, RN · 626-350-0537 · octavia@heliogenomics.com
Always discuss trial participation with your own doctor first.
| Gastroenterology and Liver Institute | Escondido, California, United States | Recruiting |
| Providence Facey Medical Foundation | Mission Hills, California, United States | Recruiting |
| UF Hepatology Research at CTRB | Gainesville, Florida, United States | Recruiting |
| Guardian Angel Research Center | Tampa, Florida, United States | Recruiting |
| South Texas Research Institute | Edinburg, Texas, United States | Recruiting |
| Texas Gastro Research | El Paso, Texas, United States | Recruiting |
| Impact Research Institute | Waco, Texas, United States | Recruiting |
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05199259